{
  "claim_id": "claim_001",
  "claim": "Flublok contains 3x the hemagglutinin (HA) antigen content of standard-dose flu vaccines, which has been linked to greater immunogenicity vs standard-dose flu vaccines.",
  "document": {
    "pdf_name": "FlublokOnePage",
    "source_pdf": "data/marketing_slide/FlublokOnePage.pdf",
    "total_pages": 1,
    "total_blocks": 19,
    "total_characters": 1730
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 2,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "AN EXACT STRAIN MATCH 4 5 The only recombinant flu vaccine that has known and exact antigen content, Flublok ensures identical antigenic match with WHO 3 x THE ANTIGEN1-3 Flublok also contains 3 x the hemagglutinin (HA) antigen content of standard dose flu vaccines, which has been linked to greater immunogenicity 3 x",
      "relevance_explanation": "This quote explicitly states that Flublok contains 3 times the hemagglutinin (HA) antigen content of standard-dose flu vaccines and directly links this higher antigen content to greater immunogenicity, supporting both parts of the claim."
    },
    {
      "id": 2,
      "quote": "in January 2024, vaccination with a higher dose recombinant flu vaccine may induce a more robust antibody response than egg based standard dose vaccines.",
      "relevance_explanation": "This quote supports the claim by stating that higher dose recombinant flu vaccines, such as Flublok, may induce a more robust antibody response compared to standard-dose, egg-based vaccines, which relates to greater immunogenicity."
    }
  ],
  "model_used": "gpt-4.1"
}